Humacyte, Inc. - COM (HUMA)

CUSIP: 44486Q103

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COM
Total 13F shares
45,803,224
Share change
-11,142,042
Total reported value
$79,706,858
Put/Call ratio
169%
Price per share
$1.74
Number of holders
138
Value change
-$20,549,961
Number of buys
51
Number of sells
74

Quarterly Holders Quick Answers

What is CUSIP 44486Q103?
CUSIP 44486Q103 identifies HUMA - Humacyte, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2025

As of 30 Sep 2025, Humacyte, Inc. - COM (HUMA) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,803,224 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, UBS Group AG, Woodline Partners LP, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 138 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.